Compensation for Tasigna (nilotinib) Atherosclerosis, Artery Disease, Amputation, Death

Tasigna (nilotinib) is a cancer drug used to treat Philadelphia chromosome-positive chronic myeloid leukemia.  Tasigna has been linked to atherosclerosis, peripheral arterial disease, amputation, coronary artery disease, stroke, and death. Tasigna causes a deadly condition called atherosclerosis, a thickening of the walls of the arteries, which causes peripheral arterial disease. Tasigna’s narrowing of arteries can lead to infections and tissue death requiring amputation, coronary artery disease, stroke, and death. The public has never been warned of Tasigna atherosclerosis.

Atherosclerosis Side Effects Associated with Tasigna

Tasigna side effects include irreversible and life threatening conditions that can result in:

  • Limb Amputation
  • Cardiovascular Problems
  • Death
  • Infections
  • Atherosclerosis
  • Peripheral Arterial Disease
  • Coronary Artery Disease
  • Tissue Death

Tasigna Atherosclerosis Information

"Evidence supporting the link between Tasigna and atherosclerosis has been published in more than a dozen studies in prominent medical journals in the United States, Canada and Europe. The first major Tasigna atherosclerosis research was published in 2011, finding that 25% of patients experienced vascular problems as a result of the drug and 16% suffered from peripheral arterial disease."

Tasigna is approved to treat Acute lymphocytic leukemia (ALL), also called acute lymphoblastic leukemia. Acute lymphocytic leukemia is a cancer that starts from the early version of white blood cells called lymphocytes in the bone marrow (the soft inner part of the bones, where new blood cells are made).

Atherosclerosis is a condition that causes the artery walls to thicken. The thickening is caused by a buildup of white blood cells and the growth of a fibrofatty plaque.

When the arterial walls thicken, the channel where blood flows becomes narrowed. This condition is known as peripheral arterial disease (PAD). PAD most commonly affects the legs, but can also occur in other arteries. The lack of proper blood circulation which occurs as a result of Tasigna atherosclerosis is severe and irreversible, causes infections and tissue death, and may require one or more limb amputations. Coronary artery disease, stroke, and death are all possible outcomes of Tasigna atherosclerosis.

Rate This Service

Did you or a loved one suffer atherosclerosis, artery disease, amputation, stroke and death after or while using the drug Tasigna?

Find out if you may qualify for compensation.

Find Out More
Copyright © 2016-2017 Consumer Safety Watch. All Rights Reserved. Privacy / Terms / Disclaimer

Consumer Safety Watch offers safety advocate services and attorney referral services for patients throughout the United States including the states of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.

Consumer Safety Watch offers consumer safety advocate services or can help you find an attorney throughout the United States including the following cities: Albuquerque, NM; Arlington, TX; Atlanta, GA; Austin, TX; Baltimore, MD; Boston, MA; Charlotte, NC; Chicago, IL; Cleveland, OH; Colorado Springs, CO; Columbus, OH; Dallas, TX; Denver, CO; Detroit, MI; Fresno, CA; Fort Worth, TX; Indianapolis, IN; Honolulu, HI; Houston, TX; Jacksonville, FL; Kansas City, KS; Kansas City, MO; Las Vegas, NV; Long Beach, CA; Los Angeles, CA; Louisville, KY; Memphis, TN; Mesa, AZ; Miami, FL; Miami, OH; Milwaukee, WI; Minneapolis, MN; Nashville, TN; New York City, NY; Oakland, CA; Oklahoma City, OK; Omaha, NE; Philadelphia, PA; Phoenix, AZ; Pittsburgh, PA; Portland, OR; Sacramento, CA; San Antonio, Tx; San Diego, CA; San Francisco, CA; San Jose, CA; Seattle, WA; St. Louis, MO; Tampa, FL; Tucson, AZ; Tulsa, Virginia Beach, VA; Washington, DC; Wichita, KS.